Cargando…

Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease

Detalles Bibliográficos
Autores principales:	Verma, Nipun, Duseja, Ajay, Singh, Virendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837182/ https://www.ncbi.nlm.nih.gov/pubmed/32553766 http://dx.doi.org/10.1053/j.gastro.2020.05.090

Ejemplares similares

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
por: Gallay, Laure, et al.
Publicado: (2021)

Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID‐19 Pandemic
por: Verma, Nipun, et al.
Publicado: (2021)

Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY
por: Singh, Virendra, et al.
Publicado: (2022)

Suitability of Tele-consultation for Hepato-biliary Diseases During Covid 19 Pandemic in India: A Machine Learning Based Approach
por: Vojjala, Nikhil, et al.
Publicado: (2022)

Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic
por: Mani, Iliana, et al.
Publicado: (2021)

Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study
por: Singh, Amandeep, et al.
Publicado: (2022)

Severe COVID-19 Associated With Liver Injury in Patients Without Preexisting Liver Disease
por: Altaf, Abeer, et al.
Publicado: (2021)

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
por: Younossi, Zobair M., et al.
Publicado: (2022)

COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022)

Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease
por: Gurala, Dhineshreddy, et al.
Publicado: (2020)

Impact of Cardiovascular Diseases on Mortality in Gastric Cancer Patients with Preexisting Chronic Disease
por: Han, Kyu-Tae, et al.
Publicado: (2022)

Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease
por: Khan, Muhammad Umair, et al.
Publicado: (2021)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
por: Jiang, Mingshan, et al.
Publicado: (2021)

Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients
por: Koyyada, Rajeswari, et al.
Publicado: (2022)

Treatment of Decompensated Alcoholic Liver Disease
por: Menachery, John, et al.
Publicado: (2011)

Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
por: Makkar, Kunaal, et al.
Publicado: (2020)

Negative impact of COVID-19 infection related to life disruption events and health scores on patients with chronic liver disease
por: Younossi, Zobair, et al.
Publicado: (2022)

COVID-19 outcomes in patients with hematologic disease
por: Malard, Florent, et al.
Publicado: (2020)

Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2023)

Quantitative liver SPECT/CT is a novel tool to assess liver function, prognosis, and response to treatment in cirrhosis
por: Kaur, Amritjyot, et al.
Publicado: (2023)

Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic
por: Silva, Clovis Artur, et al.
Publicado: (2020)

Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
por: Bergami, Maria, et al.
Publicado: (2023)

Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis()
por: Verma, Nipun, et al.
Publicado: (2023)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
por: Sohn, Won, et al.
Publicado: (2023)

The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021)

The association of preexisting severe asthma with COVID-19 outcomes
por: Terry, Paul D., et al.
Publicado: (2023)

Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
por: Weersink, Rianne A., et al.
Publicado: (2021)

Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Liver fibrosis and adverse outcomes in COVID-19
por: Huang, Jianmin
Publicado: (2021)

Correction to: Relationship between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
Publicado: (2023)

Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study
por: Martínez-Besteiro, Elisa, et al.
Publicado: (2023)

The many faces of coronavirus disease 2019: COVID-19 and the liver
por: Almas, Talal, et al.
Publicado: (2021)

Impact of new‐onset and preexisting neurological disorders in COVID‐19 patients
por: Lindemann, Sarah, et al.
Publicado: (2023)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study
por: Singh, Shailendra, et al.
Publicado: (2020)

Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini‐review of the literature
por: Verma, Nipun, et al.
Publicado: (2017)

Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
por: Dufour, Inès, et al.
Publicado: (2023)

Impact of COVID-19 vaccination on disease severity & outcomes in hospitalized patients in a tertiary care centre in the second wave
por: Mehta, Ravindra M., et al.
Publicado: (2022)

Impact of COVID-19 on Children and Pediatricians
por: Kulkarni, Rajesh K, et al.
Publicado: (2020)

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rkgt1of3t5ajg448c0vkm0j8i